APO RESEARCH · REPORT
Albumin
Albumin is a type of protein synthesized by the liver, which is present in the blood. Bovine serum albumin and human serum albumin are albumins obtained from bovine and human plasma, respectively. Recombinant albumin is manufactured using recombinant techniques in bacteria and viruses.
Product & engineering
Understand the product.
Albumin is a type of protein synthesized by the liver, which is present in the blood. Bovine serum albumin and human serum albumin are albumins obtained from bovine and human plasma, respectively. Recombinant albumin is manufactured using recombinant techniques in bacteria and viruses.
Selected research
Market Analysis & Forecast
Global Albumin Market Analysis and Forecast 2026-2032
Market perspective
Albumin is a type of protein synthesized by the liver, which is present in the blood. Bovine serum albumin and human serum albumin are albumins obtained from bovine and human plasma, respectively. Recombinant albumin is manufactured using recombinant techniques in bacteria and viruses.
Global albumin control main manufactuers include CSL, Grifols, Shire (Baxalta), Octapharma, etc., totally accounting for about 42% of the market. Asia Pacific is the largest market, with a share over 65%. As for the types of products, it can be divided into human serum albumin, bovine serum albumin and recombinant albumin. The most common product is human serum albumin, with a share over 93%. In terms of applications, it is widely used in therapeutics, vaccine ingredient, culture medium ingredient and others. The most common application is therapeutics, with a share about 72%.
This report presents an overview of global market for Albumin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
Read the full market overview
This report researches the key producers of Albumin, also provides the sales of main regions and countries. Of the upcoming market potential for Albumin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Albumin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Albumin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Albumin sales, projected growth trends, production technology, application and end-user industry.
Albumin Segment by Company
CSL
Grifols
Shire (Baxalta)
Octapharma
Hualan Bio
CBPO
RAAS
Kedrion
Merck
LFB Group
Albumedix
Thermo Fisher Scientific
Albumin Segment by Type
Human Serum Albumin
Bovine Serum Albumin
Recombinant Albumin
Albumin Segment by Application
Therapeutics
Vaccine Ingredient
Culture Medium Ingredient
Others
Albumin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Albumin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Albumin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Albumin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Albumin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Albumin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Albumin sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Human Serum Albumin
- Bovine Serum Albumin
- Recombinant Albumin
Applications
- Therapeutics
- Vaccine Ingredient
- Culture Medium Ingredient
- Others
Companies covered
- CSL
- Grifols
- Shire (Baxalta)
- Octapharma
- Hualan Bio
- CBPO
- RAAS
- Kedrion
- Merck
- LFB Group
- Albumedix
- Thermo Fisher Scientific
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Albumin Market by Type
- 1.2.1 Global Albumin Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Human Serum Albumin
- 1.2.3 Bovine Serum Albumin
- 1.2.4 Recombinant Albumin
- 1.3 Albumin Market by Application
- 1.3.1 Global Albumin Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Therapeutics
- 1.3.3 Vaccine Ingredient
- 1.3.4 Culture Medium Ingredient
- 1.3.5 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Albumin Market Dynamics
- 2.1 Albumin Industry Trends
- 2.2 Albumin Industry Drivers
- 2.3 Albumin Industry Opportunities and Challenges
- 2.4 Albumin Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Albumin Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Albumin Revenue by Region
- 3.2.1 Global Albumin Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Albumin Revenue by Region (2021-2026)
- 3.2.3 Global Albumin Revenue by Region (2027-2032)
- 3.2.4 Global Albumin Revenue Market Share by Region (2021-2032)
- 3.3 Global Albumin Sales Estimates and Forecasts 2021-2032
- 3.4 Global Albumin Sales by Region
- 3.4.1 Global Albumin Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Albumin Sales by Region (2021-2026)
- 3.4.3 Global Albumin Sales by Region (2027-2032)
- 3.4.4 Global Albumin Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Albumin Revenue by Manufacturers
- 4.1.1 Global Albumin Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Albumin Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Albumin Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Albumin Sales by Manufacturers
- 4.2.1 Global Albumin Sales by Manufacturers (2021-2026)
- 4.2.2 Global Albumin Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Albumin Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Albumin Sales Price by Manufacturers (2021-2026)
- 4.4 Global Albumin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Albumin Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Albumin Manufacturers, Product Type & Application
- 4.7 Global Albumin Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Albumin Market CR5 and HHI
- 4.8.2 2025 Albumin Tier 1, Tier 2, and Tier 3
5 Albumin Market by Type
- 5.1 Global Albumin Revenue by Type
- 5.1.1 Global Albumin Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Albumin Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Albumin Revenue Market Share by Type (2021-2032)
- 5.2 Global Albumin Sales by Type
- 5.2.1 Global Albumin Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Albumin Sales by Type (2021-2032) & (Kg)
- 5.2.3 Global Albumin Sales Market Share by Type (2021-2032)
- 5.3 Global Albumin Price by Type
6 Albumin Market by Application
- 6.1 Global Albumin Revenue by Application
- 6.1.1 Global Albumin Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Albumin Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Albumin Revenue Market Share by Application (2021-2032)
- 6.2 Global Albumin Sales by Application
- 6.2.1 Global Albumin Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Albumin Sales by Application (2021-2032) & (Kg)
- 6.2.3 Global Albumin Sales Market Share by Application (2021-2032)
- 6.3 Global Albumin Price by Application
7 Company Profiles
- 7.1 CSL
- 7.1.1 CSL Company Information
- 7.1.2 CSL Business Overview
- 7.1.3 CSL Albumin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 CSL Albumin Product Portfolio
- 7.1.5 CSL Recent Developments
- 7.2 Grifols
- 7.2.1 Grifols Company Information
- 7.2.2 Grifols Business Overview
- 7.2.3 Grifols Albumin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Grifols Albumin Product Portfolio
- 7.2.5 Grifols Recent Developments
- 7.3 Shire (Baxalta)
- 7.3.1 Shire (Baxalta) Company Information
- 7.3.2 Shire (Baxalta) Business Overview
- 7.3.3 Shire (Baxalta) Albumin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Shire (Baxalta) Albumin Product Portfolio
- 7.3.5 Shire (Baxalta) Recent Developments
- 7.4 Octapharma
- 7.4.1 Octapharma Company Information
- 7.4.2 Octapharma Business Overview
- 7.4.3 Octapharma Albumin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Octapharma Albumin Product Portfolio
- 7.4.5 Octapharma Recent Developments
- 7.5 Hualan Bio
- 7.5.1 Hualan Bio Company Information
- 7.5.2 Hualan Bio Business Overview
- 7.5.3 Hualan Bio Albumin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Hualan Bio Albumin Product Portfolio
- 7.5.5 Hualan Bio Recent Developments
- 7.6 CBPO
- 7.6.1 CBPO Company Information
- 7.6.2 CBPO Business Overview
- 7.6.3 CBPO Albumin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 CBPO Albumin Product Portfolio
- 7.6.5 CBPO Recent Developments
- 7.7 RAAS
- 7.7.1 RAAS Company Information
- 7.7.2 RAAS Business Overview
- 7.7.3 RAAS Albumin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 RAAS Albumin Product Portfolio
- 7.7.5 RAAS Recent Developments
- 7.8 Kedrion
- 7.8.1 Kedrion Company Information
- 7.8.2 Kedrion Business Overview
- 7.8.3 Kedrion Albumin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Kedrion Albumin Product Portfolio
- 7.8.5 Kedrion Recent Developments
- 7.9 Merck
- 7.9.1 Merck Company Information
- 7.9.2 Merck Business Overview
- 7.9.3 Merck Albumin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Merck Albumin Product Portfolio
- 7.9.5 Merck Recent Developments
- 7.10 LFB Group
- 7.10.1 LFB Group Company Information
- 7.10.2 LFB Group Business Overview
- 7.10.3 LFB Group Albumin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 LFB Group Albumin Product Portfolio
- 7.10.5 LFB Group Recent Developments
- 7.11 Albumedix
- 7.11.1 Albumedix Company Information
- 7.11.2 Albumedix Business Overview
- 7.11.3 Albumedix Albumin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 Albumedix Albumin Product Portfolio
- 7.11.5 Albumedix Recent Developments
- 7.12 Thermo Fisher Scientific
- 7.12.1 Thermo Fisher Scientific Company Information
- 7.12.2 Thermo Fisher Scientific Business Overview
- 7.12.3 Thermo Fisher Scientific Albumin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 Thermo Fisher Scientific Albumin Product Portfolio
- 7.12.5 Thermo Fisher Scientific Recent Developments
8 North America
- 8.1 North America Albumin Market Size by Type
- 8.1.1 North America Albumin Revenue by Type (2021-2032)
- 8.1.2 North America Albumin Sales by Type (2021-2032)
- 8.1.3 North America Albumin Price by Type (2021-2032)
- 8.2 North America Albumin Market Size by Application
- 8.2.1 North America Albumin Revenue by Application (2021-2032)
- 8.2.2 North America Albumin Sales by Application (2021-2032)
- 8.2.3 North America Albumin Price by Application (2021-2032)
- 8.3 North America Albumin Market Size by Country
- 8.3.1 North America Albumin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Albumin Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Albumin Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Albumin Market Size by Type
- 9.1.1 Europe Albumin Revenue by Type (2021-2032)
- 9.1.2 Europe Albumin Sales by Type (2021-2032)
- 9.1.3 Europe Albumin Price by Type (2021-2032)
- 9.2 Europe Albumin Market Size by Application
- 9.2.1 Europe Albumin Revenue by Application (2021-2032)
- 9.2.2 Europe Albumin Sales by Application (2021-2032)
- 9.2.3 Europe Albumin Price by Application (2021-2032)
- 9.3 Europe Albumin Market Size by Country
- 9.3.1 Europe Albumin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Albumin Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Albumin Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Albumin Market Size by Type
- 10.1.1 China Albumin Revenue by Type (2021-2032)
- 10.1.2 China Albumin Sales by Type (2021-2032)
- 10.1.3 China Albumin Price by Type (2021-2032)
- 10.2 China Albumin Market Size by Application
- 10.2.1 China Albumin Revenue by Application (2021-2032)
- 10.2.2 China Albumin Sales by Application (2021-2032)
- 10.2.3 China Albumin Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Albumin Market Size by Type
- 11.1.1 Asia Albumin Revenue by Type (2021-2032)
- 11.1.2 Asia Albumin Sales by Type (2021-2032)
- 11.1.3 Asia Albumin Price by Type (2021-2032)
- 11.2 Asia Albumin Market Size by Application
- 11.2.1 Asia Albumin Revenue by Application (2021-2032)
- 11.2.2 Asia Albumin Sales by Application (2021-2032)
- 11.2.3 Asia Albumin Price by Application (2021-2032)
- 11.3 Asia Albumin Market Size by Country
- 11.3.1 Asia Albumin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Albumin Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Albumin Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Albumin Market Size by Type
- 12.1.1 SAMEA Albumin Revenue by Type (2021-2032)
- 12.1.2 SAMEA Albumin Sales by Type (2021-2032)
- 12.1.3 SAMEA Albumin Price by Type (2021-2032)
- 12.2 SAMEA Albumin Market Size by Application
- 12.2.1 SAMEA Albumin Revenue by Application (2021-2032)
- 12.2.2 SAMEA Albumin Sales by Application (2021-2032)
- 12.2.3 SAMEA Albumin Price by Application (2021-2032)
- 12.3 SAMEA Albumin Market Size by Country
- 12.3.1 SAMEA Albumin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Albumin Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Albumin Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Albumin Value Chain Analysis
- 13.1.1 Albumin Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Albumin Production Mode & Process
- 13.2 Albumin Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Albumin Distributors
- 13.2.3 Albumin Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst